ReportWire

Tag: microclots

  • Tiny, Menacing Microclots May Explain Long COVID’s Symptoms

    Tiny, Menacing Microclots May Explain Long COVID’s Symptoms

    [ad_1]

    Tiny, Menacing Microclots May Explain Long COVID’s Symptoms


    By
    Claire Sibonney
    WebMD Health News


    Dec. 7, 2022 – When Hannah Davis saw the first visual confirmation of long COVID in her blood – a firework-like display of fluorescent green dots against a black background – she was overwhelmed with an odd sense of relief. In early November, she became one of the first U.S. long COVID patients to be tested for microscopic blood clots, catching up to South Africa, Germany, the U.K., and other countries that are already experimenting with related treatments. 


    “It was validating,” says Davis, who excitedly shared the images of her clots on Twitter. “It’s basically the first test specific to long COVID that is promising and scientifically sound and incorporates research from other post-viral illnesses.”



    <blockquote class=”twitter-tweet”><p lang=”en” dir=”ltr”>Big news: I was lucky to get tested for micro blood clots, &amp; I have a lot of them! <a href=”https://twitter.com/hashtag/LongCovid?src=hash&amp;ref_src=twsrc%5Etfw”>#LongCovid</a><br><br>Healthy control blood on the left. Mine on the right. The green is all microclots!<br><br>These clots are likely blocking oxygen from getting around my body &amp; could explain many symptoms. 1/ <a href=”https://t.co/5rtuzN8D8f”>pic.twitter.com/5rtuzN8D8f</a></p>&mdash; Hannah Davis (@ahandvanish) <a href=”https://twitter.com/ahandvanish/status/1592626664131145728?ref_src=twsrc%5Etfw”>November 15, 2022</a></blockquote> <script async src=”https://platform.twitter.com/widgets.js” charset=”utf-8″></script>


    Davis donated her blood at Mount Sinai Hospital in New York City, with a few other founding members of the Patient-Led Research Collaborative, all of whom had been infected in the first wave of the pandemic and are still sick nearly 3 years later. Seeing the pictures of their blood clots, Davis and her fellow patients cried what she called happy tears. Then the reality of having those notorious blood clots sank in.


    Early in the COVID-19 pandemic, emergency room doctors and others treating patients noticed the sickest produced excessive blood clots. The clots clogged kidney dialysis machines, caused strokes, and killed patients long after they left the hospital. Some long COVID researchers have suspected smaller, less obvious blood clots may be causing many of the puzzling symptoms reported by patients who have lasting effects of the virus.


    The theory is that these weird and persistent clots, called microclots, might be blocking delicate blood vessels throughout the body, and stopping oxygen from getting to where it needs to go, causing everything from shortness of breath and organ damage to brain fog and debilitating fatigue. But if all the havoc is being done inside these minuscule clots, regular pathology tests won’t pick it up. A network of specialists is now setting out to see if specialized tests can be accessible and if the clots can be treated.

    [ad_2]

    Source link

  • Tiny, Menacing Microclots May Explain Long COVID’s Symptoms

    Tiny, Menacing Microclots May Explain Long COVID’s Symptoms

    [ad_1]

    SOURCES:

    Hannah Davis, founding member and researcher, Patient-Led Research Collaborative.

    Etheresia (Resia) Pretorius, PhD, head of department and distinguished research professor, Physiological Sciences Department, Faculty of Science, Stellenbosch University, South Africa.

    Douglas Kell, PhD, research chair in systems biology, Department of Biochemistry, University of Liverpool, U.K.

    Michael VanElzakker, PhD, neuroscientist, Massachusetts General Hospital and Harvard Medical School; co-founder, PolyBio Research Foundation.

    Biochemical Journal: “A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.”

    Preprint, medRxiv: “Prevalence of amyloid blood clots in COVID-19 plasma.”

    Cardiovascular Diabetology: Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).”

    Bioanalytical Sciences Group: “Long COVID and the role of fibrin amyloid (fibrinaloid) microclots.”

    U.S. Government Accountability Office: “Science and Tech Spotlight: Long Covid.”

    The Guardian: “Could microclots help explain the mystery of long Covid?”

    Frontiers in Microbiology: “Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.”

    Nature Microbiology: “Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome.”

    Bioscience Reports: “SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19.”

    Clinical Infectious Diseases: “Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae.”

    YouTube: “The ‘Microclot’ Pathology of Long Covid With Dr Jaco Laubscher,” Gez Medinger:.

    Preprint, Research Square: “Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) can resolve their persistent symptoms”

    The BMJ: “Long covid patients travel abroad for expensive and experimental ‘blood washing.’”

    Studies, Surveys and Supplements: “Frequently Asked Questions: Nattokinase, Lumbrokinase & Serrapeptase.”

    [ad_2]

    Source link